Page 246 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition
P. 246
CHAPTER 13 Radiation Oncology 225
14. Poirier VJ, Mayer-Stankeova S, Buchholz J, et al.: Efficacy of radia- 40. Paganetti H: Relative biological effectiveness (RBE) values for pro-
tion therapy for the treatment of sialocele in dogs, J Vet Intern Med ton beam therapy. Variations as a function of biological endpoint,
32:107–110, 2018. dose, and linear energy transfer, Phys Med Biol 59:R419–R472,
VetBooks.ir 15. Hubler M, Volkert M, Kaser-Hotz B, et al.: Palliative irradiation 41. Tessonnier T, Mairani A, Brons S, et al.: Experimental dosimetric
2014.
of Scottish Fold osteochondrodysplasia, Vet Radiol Ultrasound
45:582–585, 2004.
Phys Med Biol 62:3958–3982, 2017.
16. Kapatkin AS, Nordquist B, Garcia TC, et al.: Effect of single dose comparison of (1)H, (4)He, (12)C and (16)O scanned ion beams,
radiation therapy on weight-bearing lameness in dogs with elbow 42. Tommasino F: Durante M: Proton radiobiology, Cancers (Basel)
osteoarthritis, Vet Comp Orthop Traumatol 29:338–343, 2016. 7:353–381, 2015.
17. Rossi F, Cancedda S, Leone VF, et al.: Megavoltage radiotherapy 43. Hendry JH: Survival of cells in mammalian tissues after low doses
for the treatment of degenerative joint disease in dogs: results of a of irradiation: a short review, Int J Radiat Biol Relat Stud Phys Chem
preliminary experience in an italian radiotherapy centre, Front Vet Med 53:89–94, 1988.
Sci 5:74, 2018. 44. West CM, Hendry JH: Intrinsic radiosensitivity as a predictor of
18. Rivers B, Walter P, McKeever J: Treatment of canine acral lick der- patient response to radiotherapy, BJR Suppl 24:146–152, 1992.
matitis with radiation therapy: 17 cases (1979-1991), J Am Anim 45. Hendry JH, West CM: Apoptosis and mitotic cell death: their rela-
Hosp Assoc 29:541–544, 1993. tive contributions to normal-tissue and tumour radiation response,
19. Owen L: Canine lick granulama treated with radiotherapy, J Sm Int J Radiat Biol 71:709–719, 1997.
Anim Pract 30:454–456, 1989. 46. Song CW, Levitt SH: Vascular changes in Walker 256 carcinoma of
20. Ward JF: DNA damage produced by ionizing radiation in mam- rats following X irradiation, Radiology 100:397–407, 1971.
malian cells: identities, mechanisms of formation, and reparability, 47. Song CW, Kim MS, Cho LC, et al.: Radiobiological basis of SBRT
Prog Nucleic Acid Res Mol Biol 35:95–125, 1988. and SRS, Int J Clin Oncol 19:570–578, 2014.
21. Compton AH: A Quantum theory of the scattering of X-rays by 48. Paris F, Fuks Z, Kang A, et al.: Endothelial apoptosis as the pri-
light elements, Phys Rev 21:483–502, 1923. mary lesion initiating intestinal radiation damage in mice, Science
22. Hall EJ, Giacca A: Physics and chemistry of radiation absorption. 293:293–297, 2001.
In Hall EJ, Giacca A, editors: Radiobiology for the radiologist, ed 8, 49. Garcia-Barros M, Paris F, Cordon-Cardo C, et al.: Tumor response
Philadelphia, 2019, Wolters Kluwer, pp 1–10. to radiotherapy regulated by endothelial cell apoptosis, Science
23. Baskar R, Dai J, Wenlong N, et al.: Biological response of cancer 300:1155–1159, 2003.
cells to radiation treatment, Front Mol Biosci 1:24, 2014. 50. Marin A, Martin M, Linan O, et al.: Bystander effects and radio-
24. Lasnitzki I: A quantitative analysis of the direct and indirect action therapy, Rep Pract Oncol Radiother 20:12–21, 2015.
of X radiation on malignant cells, Br J Radiol 20:240–247, 1947. 51. Verheij M: Clinical biomarkers and imaging for radiotherapy-
25. Ward JF: Radiation-induced strand breakage in DNA, Basic Life Sci induced cell death, Cancer Metastasis Rev 27:471–480, 2008.
5B:471–472, 1975. 52. Hewitt HB, Blake E, Proter EH: The effect of lethally irradiated
26. Carrano AV: Chromosome aberrations and radiation-induced cells on the transplantability of murine tumours, Br J Cancer
cell death. I. Transmission and survival parameters of aberrations, 28:123–135, 1973.
Mutat Res 17:341–353, 1973. 53. Hill RP, Milas L: The proportion of stem cells in murine tumors,
27. Willers H, Dahm-Daphi J, Powell SN: Repair of radiation damage Int J Radiat Oncol Biol Phys 16:513–518, 1989.
to DNA, Br J Cancer 90:1297–1301, 2004. 54. Jaggupilli A, Elkord E: Significance of CD44 and CD24 as can-
28. Santivasi WL, Xia F: Ionizing radiation-induced DNA damage, cer stem cell markers: an enduring ambiguity, Clin Dev Immunol
response, and repair, Antioxid Redox Signal 21:251–259, 2014. 2012:708036, 2012.
29. Elkind MM, Sutton H: X-ray damage and recovery in mammalian 55. Gerweck LE, Wakimoto H: At the crossroads of cancer stem cells,
cells in culture, Nature 184:1293–1295, 1959. radiation biology, and radiation oncology, Cancer Res 76:994–998,
30. Elkind MM, Sutton H: Radiation response of mammalian cells 2016.
grown in culture. 1. Repair of X-ray damage in surviving Chinese 56. Horiot JC, Le FR, N’Guyen T, et al.: Hyperfractionated compared
hamster cells, Radiat Res 13:556–593, 1960. with conventional radiotherapy in oropharyngeal carcinoma: an
31. Pawlik TM, Keyomarsi K: Role of cell cycle in mediating sensitivity EORTC randomized trial, Eur J Cancer 26:779–780, 1990.
to radiotherapy, Int J Radiat Oncol Biol Phys 59:928–942, 2004. 57. Horiot JC, Bontemps P, Van Den Bogaert W, et al.: Accelerated
32. Lange SS, Takata K, Wood RD: DNA polymerases and cancer, Nat fractionation (AF) compared to conventional fractionation (CF)
Rev Cancer 11:96–110, 2011. improves loco-regional control in the radiotherapy of advanced
33. Withers HR, Thames HD: Dose fractionation and volume effects head and neck cancers: results of the EORTC 22851 randomized
in normal tissues and tumors, Am J Clin Oncol 11:313–329, 1988. trial, Radiother Oncol 44:111–121, 1997.
34. Terasima T, Tolmach LJ: Changes in x-ray sensitivity of HeLa cells 58. Thames HD, Hendry JH: Response of tissues to fractionated irradi-
during the division cycle, Nature 190:1210–1211, 1961. ation: effect of repair. In Anonymous. Fractionation in radiotherapy,
35. Thomlinson RH, Gray LH: The histological structure of some Philadelphia, 1987, Taylor and Francis, pp 53–99.
human lung cancers and the possible implications for radiotherapy, 59. Vaupel P, Mayer A: Tumor oxygenation status: facts and fallacies,
Br J Cancer 9:539–549, 1955. Adv Exp Med Biol 977:91–99, 2017.
36. Vaupel P, Mayer A: Tumor hypoxia: causative mechanisms, micro- 60. Rockwell S, Moulder JE: Hypoxic fractions of human tumors xeno-
regional heterogeneities, and the role of tissue-based hypoxia mark- grafted into mice: a review, Int J Radiat Oncol Biol Phys 19:197–
ers, Adv Exp Med Biol 923:77–86, 2016. 202, 1990.
37. Vaupel P: Tumor microenvironmental physiology and its impli- 61. Rockwell S, Moulder JE, Martin DF: Tumor-to-tumor variability
cations for radiation oncology, Semin Radiat Oncol 14:198–206, in the hypoxic fractions of experimental rodent tumors, Radiother
2004. Oncol 2:57–64, 1984.
38. Hall EJ, Giaccia AJ: Linear Energy transfer and relative biologica 62. Withers HR, Taylor JM, Maciejewski B: The hazard of acceler-
effectiveness. In Hall EJ, Giaccia AJ, editors: Radiobiology for the ated tumor clonogen repopulation during radiotherapy, Acta Oncol
radiologist, ed 8, Philadelphia, 2019, Wolters Kluwer, pp 101–110. 27:131–146, 1988.
39. Anonymous: International Commison on Radiological Protection: 63. Barendsen GW, Roelse H, Hermens AF, et al.: Clonogenic capac-
Relative biological effectiveness (RBE), quality factor (Q), and radi- ity of proliferating and nonproliferating cells of a transplantable rat
ation weighting factor (Wr). In Anonymous. ICRP ed 60, Oxford, rhabdomyosarcoma in relation to its radiosensitivity, J Natl Cancer
2004, Elsevier Science. Inst 51:1521–1526, 1973.